SARS-CoV-2 recombinant spike protein · Medicine question

What is Nuvaxovid JN.1 used to prevent, and in which age group is it indicated?

Name: What is Nuvaxovid JN.1 used to prevent, and in which age group is it indicated?
Published: 2026-11-08T01:31:46.315Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Nuvaxovid JN.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals aged 12 years and older, in accordance with official recommendations.

Sources for this answer

Nuvaxovid JN.1 dispersion for injection in pre-filled syringeSANOFI · emc · SmPC §4.1 Therapeutic Indications · Version 4Document updated 14 April 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about SARS-CoV-2 recombinant spike protein